Marc Schegerin
Director of Finance/CFO chez MORPHIC HOLDING, INC.
Fortune : 1 M $ au 30/04/2024
Postes actifs de Marc Schegerin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MORPHIC HOLDING, INC. | Chief Operating Officer | 06/04/2020 | - |
| Director of Finance/CFO | 06/04/2020 | - | |
| SQZ BIOTECHNOLOGIES COMPANY | Director/Board Member | 23/10/2020 | - |
| Independent Dir/Board Member | 23/10/2020 | - | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Chief Operating Officer | 01/04/2020 | - |
| Director of Finance/CFO | 01/04/2020 | - |
Historique de carrière de Marc Schegerin
Anciens postes connus de Marc Schegerin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ARQULE, INC. | Director of Finance/CFO | 29/03/2019 | 01/01/2020 |
| Public Communications Contact | 24/05/2018 | 29/03/2019 | |
| CITIGROUP INC. | Director/Board Member | 01/06/2016 | 01/04/2018 |
| SAGE THERAPEUTICS, INC. | Director/Board Member | 01/01/2013 | 01/01/2014 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2009 | 01/01/2013 |
Formation de Marc Schegerin
| Harvard University | Undergraduate Degree |
| Tulane University (Louisiana) | Undergraduate Degree |
| Dartmouth Medical School | Doctorate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 12 |
Opérationnelle
| Director/Board Member | 3 |
| Director of Finance/CFO | 3 |
| Chief Operating Officer | 2 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 5 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| BIOGEN INC. | Health Technology |
| CITIGROUP INC. | Finance |
| SQZ BIOTECHNOLOGIES COMPANY | Health Technology |
| SAGE THERAPEUTICS, INC. | Health Technology |
| MORPHIC HOLDING, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Marc Schegerin
- Expérience
